Back to top

immuno-therapy: Archive

Zacks Equity Research

Biogen Inks Research Deal With Dayra to Boost Immunology Pipeline

BIIB's research deal with Dayra targets oral macrocyclic peptides to advance its immunology pipeline and expand next-generation therapies.

BIIBPositive Net Change ADMANegative Net Change EDITNegative Net Change ARQTPositive Net Change